Using animal-derived constituents in anaesthesia and surgery: the case for disclosing to patients

Background Animal-derived constituents are frequently used in anaesthesia and surgery, and patients are seldom informed of this. This is problematic for a growing minority of patients who may have religious or secular concerns about their use in their care. It is not currently common practice to inf...

Full description

Saved in:
Bibliographic Details
Published inBMC medical ethics Vol. 20; no. 1; pp. 14 - 9
Main Authors Rodger, Daniel, Blackshaw, Bruce P.
Format Journal Article
LanguageEnglish
Published London BioMed Central 18.02.2019
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1472-6939
1472-6939
DOI10.1186/s12910-019-0351-4

Cover

More Information
Summary:Background Animal-derived constituents are frequently used in anaesthesia and surgery, and patients are seldom informed of this. This is problematic for a growing minority of patients who may have religious or secular concerns about their use in their care. It is not currently common practice to inform patients about the use of animal-derived constituents, yet what little empirical data does exist indicates that many patients want the opportunity to give their informed consent. Discussion First we review the nature and scale of the problem by looking at the groups who may have concerns about the use of animal-derived constituents in their care. We then summarise some of the products used in anaesthesia and surgery that can contain such constituents, such as anaesthetic drugs, surgical implants and dressings. Finally, we explore the problem of animal-derived constituents and consent using Beauchamp and Childress’ four principles approach, examining issues of autonomy, beneficence, nonmaleficence and justice. Summary Disclosing the use of animal-derived constituents in anaesthesia and surgery is warranted under Beauchamp and Childress’ four principles approach to the problem. Although there exist systemic and practical challenges to implementing this in practice, the ethical case for doing so is strong. The Montgomery ruling presents additional legal reason for disclosure because it entails that patients must be made aware of risks associated with their treatment that they attach significance to.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1472-6939
1472-6939
DOI:10.1186/s12910-019-0351-4